Sirolimus and gastrointestinal angiodysplasia: Can an established agent change the way gastrointestinal bleeding is managed?
Sign Up to like & getrecommendations! Published in 2025 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v31.i41.113736
Abstract: Gastrointestinal angiodysplasia (GIAD) is a common, acquired, vascular abnormality in the gastrointestinal tract that is commonly implicated in bleeding. Sirolimus, also known as rapamycin, is a mammalian target of rapamycin pathway inhibitor that has shown… read more here.
Keywords: associated bleeding; gastrointestinal angiodysplasia; giad associated; angiodysplasia ... See more keywords